Interferons
Showing 1 - 25 of 1,152
Czech Pharmaco-epidemiological Study on Disease Modifying Drugs
Completed
- Multiple Sclerosis
- interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab
-
Prague, CzechiaIMPULS Endowment Fund
Mar 7, 2023
Gene Expression Of Suppressor Of Cytokines in In Cutaneous Warts
Not yet recruiting
- Warts
- Detection of expression of SOCS3 gene
- +2 more
- (no location specified)
Mar 12, 2023
Stage IV Melanoma Trial in Cleveland (recombinant interferon alfa-2b, cisplatin, sodium stibogluconate)
Completed
- Stage IV Melanoma
- recombinant interferon alfa-2b
- +4 more
-
Cleveland, OhioCleveland Clinic Taussig Institute, Case Comprehensive Cancer Ce
Jul 22, 2020
Long-Term Safety of Vumerity and Tecfidera in Multiple Sclerosis
Not yet recruiting
- Multiple Sclerosis
- Diroximel Fumarate
- +2 more
- (no location specified)
Mar 2, 2023
Relapsing-Remitting Multiple Sclerosis (RRMS) Trial in Italy (peginterferon beta-1a)
Completed
- Relapsing-Remitting Multiple Sclerosis (RRMS)
- peginterferon beta-1a
-
Arezzo, Italy
- +29 more
Dec 24, 2019
Sarcoma, Kaposi, HIV Trial in Miami (Interferon alfa-2a, Zidovudine, Interferon alfa-n1)
Completed
- Sarcoma, Kaposi
- HIV Infections
- Interferon alfa-2a
- +2 more
-
Miami, FloridaUniv of Miami School of Medicine
Oct 27, 2021
Sarcoma, Kaposi, HIV Trial in New York (Interferon alfa-2a, Zidovudine, Interferon alfa-n1)
Completed
- Sarcoma, Kaposi
- HIV Infections
- Interferon alfa-2a
- +2 more
-
New York, New YorkMem Sloan - Kettering Cancer Ctr
Oct 28, 2021
COVID-19, INTERFERON, NEBULIZATION Trial in France (inhaled type I interferon, WFI water nebulization)
Recruiting
- COVID-19
- +2 more
- inhaled type I interferon
- WFI water nebulization
-
Abbeville, France
- +6 more
Jan 3, 2022
COVID-19, SARS-CoV2 Infection Trial in New Haven (Neosporin, Vaseline)
Recruiting
- COVID-19
- SARS-CoV2 Infection
- Neosporin
- Vaseline
-
New Haven, ConnecticutYale University
Sep 12, 2022
Hypertrophic Scar Trial in Islamabad, Rawalpindi (Microneedling, Percutaneous Collagen Induction)
Recruiting
- Hypertrophic Scar
- Microneedling
- Percutaneous Collagen Induction
-
Islamabad, Federal, Pakistan
- +1 more
Nov 3, 2021
Essential Thrombocytopenia Trial in Tianjin (Recombinant Interferon Alpha, Pegylated interferon alfa-2b)
Recruiting
- Essential Thrombocytopenia
- Recombinant Interferon Alpha
- Pegylated interferon alfa-2b
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Jul 18, 2022
CD4/CD8+ Interferon Gamma Release Assay for Monitoring
Active, not recruiting
- Tuberculosis
- Interferon gamma release assay (IGRA)
-
Milano, ItalyIRCCS San Raffaele Scientific Institute
Feb 13, 2023
Hepatocellular Carcinoma, Chronic Hepatitis B Trial in Xiamen (NAs("Entecavir"or"Tenofovir"or"Tenofovir alafenamide") combined
Recruiting
- Hepatocellular Carcinoma
- Chronic Hepatitis B
- NAs("Entecavir"or"Tenofovir"or"Tenofovir alafenamide") combined with interferon treatments
- NAs ("Entecavir"or"Tenofovir"or"Tenofovir alafenamide") treatments
-
Xiamen, Fujian, ChinaBoheng Zhang
Feb 7, 2023
Angiosarcoma Trial in Houston (Paclitaxel, mRNA plus Lysate-loaded Dendritic Cell Vaccine, PEGYLATED-INTERFERON ALPHA-2A)
Not yet recruiting
- Angiosarcoma
- Paclitaxel
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Mar 23, 2023
Lupus Erythematosus, Systemic Trial in Beijing (low dose GR1603 in phase ?b, high dose GR1603 in phase?b, low dose GR1603 in
Recruiting
- Lupus Erythematosus, Systemic
- low dose GR1603 in phase Ⅰb
- +4 more
-
Beijing, Beijing, ChinaPeking union Medical Hosipital
Aug 22, 2023
Chronic Pulmonary Aspergillosis, Aspergillosis Trial (Interferon Gamma-1B 0.1 MG Per 0.5 ML Injection PLUS antifungals as
Not yet recruiting
- Chronic Pulmonary Aspergillosis
- Aspergillosis
- Interferon Gamma-1B 0.1 MG Per 0.5 ML Injection PLUS antifungals as standard of care
- Antifungals as standard of care
- (no location specified)
Dec 13, 2022
Chronic Hepatitis B Virus Infection Trial in Worldwide (PEG-IFNa, BRII-835)
Not yet recruiting
- Chronic Hepatitis B Virus Infection
- PEG-IFNα
- BRII-835
-
Kingswood, New South Wales, Australia
- +28 more
Jul 21, 2023
Herpes Zoster Trial (Recombinant Human Interferon a-2b Gel (After the Alteration), Recombinant Human Interferon a-2b Gel (Before
Not yet recruiting
- Herpes Zoster
- Recombinant Human Interferon α-2b Gel (After the Alteration)
- Recombinant Human Interferon α-2b Gel (Before the Alteration)
- (no location specified)
Apr 7, 2023
HPV Infection Trial (Human interferon alpha 2b vaginal Effervescent capsules)
Not yet recruiting
- HPV Infection
- Human interferon alpha 2b vaginal Effervescent capsules
- (no location specified)
May 8, 2023
Blood Collection From People With Ovarian Cancer
Completed
- Ovarian Cancer
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 7, 2022
Assess Pregnancy Outcomes in Women Exposed to Diroximel Fumarate
Recruiting
- Multiple Sclerosis
- Diroximel Fumarate
- +8 more
-
Eden Prairie, MinnesotaOptumInsight
Jan 9, 2023
Acute Stroke, Acute Ischemic Stroke, Ischemic Stroke Trial in Albuquerque (Serum and Urine measurement of cytokines.)
Completed
- Acute Stroke
- +3 more
- Serum and Urine measurement of cytokines.
-
Albuquerque, New MexicoDepartment of Neurology, University of New Mexico
Jan 25, 2022
Pneumonia, Ventilator-Associated Trial in France (Interferon gamma, Placebo)
Not yet recruiting
- Pneumonia, Ventilator-Associated
- Interferon gamma
- Placebo
-
Lyon, France
- +6 more
May 2, 2023
Kohlmeier Degos Disease With Neurologic Involvement Trial run by the National Heart, Lung, and Blood Institute (NHLBI)
Recruiting
- Kohlmeier Degos Disease With Neurologic Involvement
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 23, 2023
COVID-19 Infection and Its Clinical Prognosis in Chronic
Recruiting
- Chronic Hepatitis B
- COVID-19 Infection
- Interferon
- nucleoside analogues
-
Beijing, Beijing, ChinaDepartment of Hepatology Division 2, Beijing Ditan Hospital
Mar 28, 2023